FIGURE 2.
Kaplan-Meier estimates of overall 6-year outcomes in children with Alagille syndrome treated with maralixibat. (A) EFS. (B) TFS. The dashed line indicates a 75% survival threshold. The shaded area indicates 95% confidence limits. Abbreviations: EFS, event-free survival; TFS, transplant-free survival.